US Patent Issued to Regeneron Pharmaceuticals on Aug. 4 for "Mammalian cells comprising integrated CAS9 genes to produce stable integration sites, and mammalian cells comprising stable integration sites and other sites" (New York Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,514, issued on Aug. 4, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Mammalian cells comprising integrated CAS9 genes to produce stable integration sites, and mammalian cells comprising stable integration sites and other sites" was invented by Michael Goren (Tarrytown, N.Y.), Darya Burakov (Tarrytown, N.Y.), Gang Chen (Yorktown Heights, N.Y.), Yu Zhao (Willison Park, N.Y.) and Dipali Deshpande (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present inventions provide mammalian cells that comprise multiple Stable Integration Sites. The inventions provide sites introduced genomically into a Genomic Safe Harbor a...